Skip to main content
Clinical Trials/NCT04962464
NCT04962464
Unknown
Phase 2

The Impact of Fasting Mimicking Diet Program and Calorie Mimetic Supplements on Epigenetic Aging

TruDiagnostic1 site in 1 country100 target enrollmentMarch 10, 2021
ConditionsAging

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Aging
Sponsor
TruDiagnostic
Enrollment
100
Locations
1
Primary Endpoint
Epigenetic Age Biomarkers
Last Updated
4 years ago

Overview

Brief Summary

This is a prospective randomized clinical study of 50 patients to evaluate the fasting mimicking diet program by Prolon with a calorie mimetic supplement from Peak Human Labs. This study will be evaluating the effectiveness of the combined intervention over a three month program.

The study will assess the effects that the program has on the participants' biological aging.

Registry
clinicaltrials.gov
Start Date
March 10, 2021
End Date
September 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
TruDiagnostic
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy individuals
  • Age \> 16 years

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Epigenetic Age Biomarkers

Time Frame: Change from baseline to 6 months

Outcome epigenetic age testing will test methylation at 850,000 spots on the DNA/

Secondary Outcomes

  • Body Mass Index(Change from baseline to 6 months)

Study Sites (1)

Loading locations...

Similar Trials